Leland Gershell
Stock Analyst at Oppenheimer
(3.74)
# 2,066
Out of 5,090 analysts
728
Total ratings
37.7%
Success rate
4.3%
Average return
Main Sectors:
Stocks Rated by Leland Gershell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $326 → $346 | $322.75 | +7.20% | 5 | Oct 30, 2026 | |
| URGN UroGen Pharma | Reiterated: Buy | $60 | $32.72 | +83.37% | 49 | Oct 28, 2026 | |
| AARD Aardvark Therapeutics | Downgraded: Hold | n/a | $1.36 | - | 3 | Oct 26, 2026 | |
| AVTX Avalo Therapeutics | Reiterated: Buy | $35 → $16 | $7.17 | +123.15% | 29 | Oct 26, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,038 | $892.87 | +16.25% | 21 | Oct 23, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $8 | $1.16 | +589.66% | 3 | Oct 21, 2026 | |
| CGEN Compugen | Reiterated: Buy | $4 | $1.98 | +102.02% | 4 | Oct 6, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $10 | $0.7027 | +1,323.08% | 3 | Sep 29, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $20 | $3.14 | +536.94% | 4 | Sep 23, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $262 → $312 | $251.27 | +24.17% | 38 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $54 | $6.38 | +746.39% | 28 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $46.39 | +395.80% | 6 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.37 | +410.95% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $14 | $2.62 | +434.35% | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $97 | $58.51 | +65.78% | 39 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.25 | +75.61% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $29.17 | +85.12% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $13.56 | +84.37% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.53 | - | 8 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.71 | - | 2 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.35 | +317.91% | 7 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $2.48 | +1,029.03% | 21 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.46 | +584.93% | 16 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $24.67 | - | 34 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.19 | +1,041.55% | 44 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $20.87 | - | 7 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.71 | +68.07% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $92.57 | - | 6 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $19.78 | n/a | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $490 | $165.00 | n/a | 42 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.01 | n/a | 20 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 | $62.99 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.44 | n/a | 19 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.35 | n/a | 17 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.73 | n/a | 19 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.94 | n/a | 16 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.83 | n/a | 6 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $0.13013 | n/a | 11 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $200 | $0.000001 | n/a | 11 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.22 | n/a | 16 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.0006 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $0.42788 | n/a | 11 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $0.75 | n/a | 16 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $1.16 | n/a | 7 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0111 | n/a | 4 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.41 | n/a | 22 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.11 | n/a | 13 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.4681 | n/a | 9 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.006 | n/a | 15 | Sep 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.12 | n/a | 3 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.03 | n/a | 9 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.96 | n/a | 9 | Apr 3, 2019 |
Ligand Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $326 → $346
Current: $322.75
Upside: +7.20%
UroGen Pharma
Oct 28, 2026
Reiterated: Buy
Price Target: $60
Current: $32.72
Upside: +83.37%
Aardvark Therapeutics
Oct 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.36
Upside: -
Avalo Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $35 → $16
Current: $7.17
Upside: +123.15%
argenx SE
Oct 23, 2026
Reiterated: Buy
Price Target: $1,038
Current: $892.87
Upside: +16.25%
Palisade Bio
Oct 21, 2026
Reiterated: Buy
Price Target: $8
Current: $1.16
Upside: +589.66%
Compugen
Oct 6, 2026
Reiterated: Buy
Price Target: $4
Current: $1.98
Upside: +102.02%
Ocugen
Sep 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.7027
Upside: +1,323.08%
Lexeo Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $20
Current: $3.14
Upside: +536.94%
Ascendis Pharma
Sep 2, 2026
Reiterated: Buy
Price Target: $262 → $312
Current: $251.27
Upside: +24.17%
Aug 25, 2026
Upgraded: Buy
Price Target: $54
Current: $6.38
Upside: +746.39%
Aug 25, 2026
Reiterated: Buy
Price Target: $230
Current: $46.39
Upside: +395.80%
Aug 14, 2026
Rated: Buy
Price Target: $7
Current: $1.37
Upside: +410.95%
Aug 14, 2026
Reiterated: Buy
Price Target: $30 → $14
Current: $2.62
Upside: +434.35%
Aug 7, 2026
Rated: Buy
Price Target: $98 → $97
Current: $58.51
Upside: +65.78%
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $10.25
Upside: +75.61%
Aug 7, 2026
Reiterated: Buy
Price Target: $54
Current: $29.17
Upside: +85.12%
Aug 7, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $13.56
Upside: +84.37%
Jun 22, 2026
Rated: Hold
Price Target: n/a
Current: $1.53
Upside: -
Jun 22, 2026
Rated: Hold
Price Target: n/a
Current: $3.71
Upside: -
Jun 15, 2026
Reiterated: Buy
Price Target: $14
Current: $3.35
Upside: +317.91%
May 20, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $2.48
Upside: +1,029.03%
May 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%
Apr 13, 2026
Rated: Hold
Price Target: n/a
Current: $24.67
Upside: -
Feb 12, 2026
Reiterated: Buy
Price Target: $25
Current: $2.19
Upside: +1,041.55%
Feb 10, 2026
Rated: Hold
Price Target: n/a
Current: $20.87
Upside: -
Nov 7, 2025
Reiterated: Buy
Price Target: $18
Current: $10.71
Upside: +68.07%
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $92.57
Upside: -
Sep 3, 2025
Initiated Coverage: Buy
Price Target: $80
Current: $19.78
Upside: n/a
Aug 4, 2025
Upgraded: Buy
Price Target: $490
Current: $165.00
Upside: n/a
Sep 16, 2024
Reiterated: Buy
Price Target: $25
Current: $1.01
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $106
Current: $62.99
Upside: n/a
Mar 28, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $1.44
Upside: n/a
Dec 18, 2023
Reiterated: Buy
Price Target: n/a
Current: $3.35
Upside: n/a
Nov 13, 2023
Reiterated: Buy
Price Target: $11
Current: $0.73
Upside: n/a
Jul 10, 2023
Reiterated: Buy
Price Target: n/a
Current: $1.94
Upside: n/a
Oct 4, 2022
Downgraded: Hold
Price Target: n/a
Current: $3.83
Upside: n/a
May 26, 2022
Reiterated: Buy
Price Target: $60
Current: $0.13013
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: $70 → $200
Current: $0.000001
Upside: n/a
Nov 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $4.22
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.0006
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: $12
Current: $0.42788
Upside: n/a
May 18, 2021
Rated: Buy
Price Target: $7
Current: $0.75
Upside: n/a
May 7, 2021
Initiated Coverage: Buy
Price Target: $42
Current: $1.16
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.0111
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $11.41
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $12.11
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $0.4681
Upside: n/a
Sep 11, 2020
Rated: Hold
Price Target: n/a
Current: $0.006
Upside: n/a
May 10, 2019
Reiterated: Buy
Price Target: $7
Current: $1.12
Upside: n/a
May 9, 2019
Rated: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
Apr 3, 2019
Reiterated: Buy
Price Target: $8
Current: $4.96
Upside: n/a